Search Result "resistance to proteasome inhibitors"
Macrocyclic Proteasome Inhibitors
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 3 Year: 2011 Page: 5052-5060
Author(s): D. Krahn, C. Ottmann, M. Kaiser
The Ubiquitin-Proteasome Pathway and Resistance Mechanisms Developed Against the Proteasomal Inhibitors in Cancer Cells
Journal: Current Drug Targets
Volume: 21 Issue: 13 Year: 2020 Page: 1313-1325
Author(s): Azmi Yerlikaya,Ertan Kanbur
Proteasome Regulators: Activators and Inhibitors
Journal: Current Medicinal Chemistry
Volume: 16 Issue: 8 Year: 2009 Page: 931-939
Author(s): Li Huang, Chin Ho Chen
Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System
Journal: Current Cancer Drug Targets
Volume: 14 Issue: 6 Year: 2014 Page: 517-536
Author(s): Q. Ping Dou,Jeffrey A. Zonder
Proteasome Inhibitors in Cancer Therapy
Journal: Current Drug Targets
Volume: 10 Issue: 1 Year: 2009 Page: 968-981
Author(s): Ugo Testa
Non-Covalent Proteasome Inhibitors
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 4115-4130
Author(s): Julia Kaffy, Guillaume Bernadat, Sandrine Ongeri
The Efficacy and Mechanism of Proteasome Inhibitors in Solid Tumor Treatment
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 17 Issue: 3 Year: 2022 Page: 268-283
Author(s): Lei Zhang,Mengyang Wu,Ruicong Su,Di Zhang,Guilian Yang
Natural Proteasome Inhibitors for Battling Cancer
Ebook: Advances in Protein and Peptide Sciences
Volume: 1 Year: 2013
Author(s): Huanjie Yang,Kristin R. Landis-Piwowar,Di Chen,Vesna Milacic,Q. Ping Dou
Doi: 10.2174/9781608054879113010010
From Bortezomib to other Inhibitors of the Proteasome and Beyond
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 4025-4038
Author(s): Daniela Buac, Min Shen, Sara Schmitt, Fathima Rani Kona, Rahul Deshmukh, Zhen Zhang, Christine Neslund-Dudas, Bharati Mitra, Q. Ping Dou
Second Generation Proteasome Inhibitors: Carfilzomib and Immunoproteasome-Specific Inhibitors (IPSIs)
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 3 Year: 2011 Page: 285-295
Author(s): D. J. Kuhn, R. Z. Orlowski, C. C. Bjorklund